Why Is Monarch (MCRI) Stock Rocketing Higher Today
Shares of luxury casino and resort operator Monarch (NASDAQ:MCRI) jumped 22% in the afternoon session after the company reported record financial results for the second quarter of 2025, significantly beating analyst expectations.
The casino operator announced record net revenue of $136.9 million, a 6.8% increase year-over-year, and a 19.1% jump in net income to $27 million. Diluted earnings per share (EPS) came in at $1.44, handily beating the consensus estimate of $1.22. The strong performance was driven by a 12.1% surge in casino revenue. The company's Adjusted EBITDA, a key measure of profitability that excludes interest, taxes, depreciation, and amortization, rose 16.8% to a record $51.3 million.
CEO John Farahi credited the results to operational efficiencies and market share gains at its properties in Reno, Nevada, and Black Hawk, Colorado. Following the strong report, Wall Street analysts reacted positively. Wells Fargo upgraded the stock from "Underweight" to "Equal Weight" and raised its price target to $89, citing consistent performance and a strong free cash flow profile. Stifel also increased its price target from $81 to $92.
Is now the time to buy Monarch? Access our full analysis report here, it's free.
What Is The Market Telling Us
Monarch's shares are not very volatile and have only had 5 moves greater than 5% over the last year. Moves this big are rare for Monarch and indicate this news significantly impacted the market's perception of the business.
Monarch is up 35.7% since the beginning of the year, and at $105.47 per share, has set a new 52-week high. Investors who bought $1,000 worth of Monarch's shares 5 years ago would now be looking at an investment worth $3,001.
Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
MBX Biosciences Submits IND for Once-Monthly Obesity Drug
MBX Biosciences Inc. (NASDAQ:MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX Biosciences announced the submission of an Investigational New Drug/IND application to the US FDA for MBX 4291. This drug is a long-acting GLP-1/GIP receptor co-agonist prodrug being developed for the treatment of obesity. The company's President and CEO, Kent Hawryluk, stated that MBX 4291 is designed to be a potential once-monthly injectable, which could offer less frequent dosing and improved gastrointestinal tolerability, potentially leading to better patient adherence and increased weight loss. MBX 4291 was created using the company's proprietary Precision Endocrine Peptide/PEP platform. A doctor holding a test tube of the biopharmaceutical company's NicAlert drug product while providing patient care. In preclinical studies, the active component of MBX 4291 demonstrated a similar activity profile and body weight loss as tirzepatide, a weekly GLP-1/GIP co-agonist that is already approved. Furthermore, these preclinical studies showed an extended duration of action for MBX 4291's active component compared to tirzepatide, supporting the potential for once-monthly administration. MBX Biosciences Inc. (NASDAQ:MBX) is a clinical-stage biopharmaceutical company that discovers and develops precision peptide therapies for the treatment of endocrine and metabolic disorders. While we acknowledge the potential of MBX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
3 hours ago
- Business Insider
Guggenheim Remains a Buy on Nexstar Media Group (NXST)
In a report released today, Curry Baker from Guggenheim maintained a Buy rating on Nexstar Media Group, with a price target of $250.00. The company's shares closed today at $207.73. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Baker covers the Communication Services sector, focusing on stocks such as Liberty Media Liberty Formula One, Liberty Media Liberty Formula One, and Live Nation Entertainment. According to TipRanks, Baker has an average return of 12.4% and a 64.17% success rate on recommended stocks. In addition to Guggenheim, Nexstar Media Group also received a Buy from Barrington's Patrick Sholl in a report issued today. However, on August 15, Citi maintained a Hold rating on Nexstar Media Group (NASDAQ: NXST).
Yahoo
4 hours ago
- Yahoo
What To Expect From Workday's (WDAY) Q2 Earnings
Enterprise software company Workday (NASDAQ:WDAY) will be reporting results this Thursday after market hours. Here's what investors should know. Workday beat analysts' revenue expectations by 1% last quarter, reporting revenues of $2.24 billion, up 12.6% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts' EBITDA estimates but a significant miss of analysts' billings estimates. Is Workday a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Workday's revenue to grow 12.3% year on year to $2.34 billion, slowing from the 16.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.11 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Workday has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 0.9% on average. Looking at Workday's peers in the finance and hr software segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Marqeta delivered year-on-year revenue growth of 20.1%, beating analysts' expectations by 6.9%, and Workiva reported revenues up 21.2%, topping estimates by 3%. Marqeta traded up 19.9% following the results while Workiva was also up 32.2%. Read our full analysis of Marqeta's results here and Workiva's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the finance and hr software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.6% on average over the last month. Workday is down 1.5% during the same time and is heading into earnings with an average analyst price target of $293.69 (compared to the current share price of $230.17). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
